Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function

Sungim CHOI; Heun CHOI; Seong-Yeon PARK; Yee-Gyung KWAK; Je-Eun SONG; So-Youn SHIN; Ji-Hyeon BAEK; Hyun-IL SHIN; Hong-Sang OH; Yong-Chan KIM; Joon-Sup YEOM; Jin-Hee HAN; Min-Jae KIM.
The Korean Journal of Parasitology ; : 39-43, 2022.
Artículo en Inglés | WPRIM | ID: wpr-927078

Documentos relacionados

  1. Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function.
  2. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
  3. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
  4. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
  5. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
  6. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
  7. Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia.
  8. Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against <i>Plasmodium vivax</i> in Australian Defence Force personnel.
  9. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
  10. Association between CYP2D6 phenotype and recurrence of Plasmodium vivax infection in south Korean patients.